Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
20,4 USD | -3,68% | -5,51% | +158,56% |
03/04 | JASPER THERAPEUTICS, INC. : Evercore ISI è per il Buy | ZM |
28/03 | JASPER THERAPEUTICS, INC. : RBC Capital Markets mantiene la raccomandazione Buy | ZM |
Attività
Numero di dipendenti: 45
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15/03/22 |
Herbert Cross
DFI | Director of Finance/CFO | 52 | 22/09/23 |
Luca Di Noto
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Wendy Pang
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Edwin Tucker
CTO | Chief Tech/Sci/R&D Officer | 52 | 12/06/23 |
Jeet Mahal
COO | Chief Operating Officer | 52 | 01/12/19 |
Matthew Ford
HRO | Human Resources Officer | - | 13/04/23 |
David Hinds
PRN | Corporate Officer/Principal | - | 10/04/23 |
Patricia Carlos
LAW | General Counsel | - | 02/08/23 |
Arjun Agarwal
AUD | Comptroller/Controller/Auditor | - | 01/01/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Ronald Martell
CEO | Chief Executive Officer | 62 | 15/03/22 |
Thomas Wiggans
CHM | Chairman | 72 | 01/11 |
Kurt von Emster
BRD | Director/Board Member | 56 | 24/09/21 |
Scott Brun
BRD | Director/Board Member | 56 | 20/06/23 |
Vishal Kapoor
BRD | Director/Board Member | 48 | 16/02/23 |
Christian Nolet
BRD | Director/Board Member | 67 | 24/09/21 |
Anna Phil
BRD | Director/Board Member | 36 | 24/09/19 |
Judith Shizuru
FOU | Founder | 68 | 01/03/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 15 085 553 | 14 084 125 ( 93,36 %) | 0 | 93,36 % |
Coordinate società
Jasper Therapeutics, Inc.
2200 Bridge Parkway Suite 102
94065, Redwood City
+
http://www.jaspertherapeutics.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+158,56% | 308 Mln | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione JSPR
- Società Jasper Therapeutics, Inc.